title: Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial).
abstract: BACKGROUND
  There is growing evidence that home telemonitoring can be advantageous in societies with increasing prevalence of chronic diseases.The main objective of this study is to evaluate the effect of a primary care-based telemonitoring intervention on the number and length of hospital admissions.
  
  
  METHODS
  A randomised controlled trial was carried out across 20 health centres in Bilbao (Basque Country, Spain) to assess the impact of home telemonitoring on in-home chronic patients compared with standard care. The study lasted for one year. Fifty-eight in-home patients, diagnosed with heart failure (HF) and/or chronic lung disease (CLD), aged 14 or above and with two or more hospital admissions in the previous year were recruited. The intervention consisted of daily patient self-measurements of respiratory-rate, heart-rate, blood pressure, oxygen saturation, weight, body temperature and the completion of a health status questionnaire using PDAs. Alerts were generated when pre-established thresholds were crossed. The control group (CG) received usual care. The primary outcome measure was the number of hospital admissions that occurred at 12 months post-randomisation. The impact of telemonitoring on the length of hospital stay, use of other healthcare resources and mortality was also explored.
  
  
  RESULTS
  The intervention group (IG) included 28 patients and the CG 30. Patient baseline characteristics were similar in both groups. Of the 21 intervention patients followed-up for a year, 12 had some admissions (57.1%), compared to 19 of 22 controls (86.4%), being the difference statistically significant (p = 0.033, RR 0.66; 95%CI 0.44 to 0.99). The mean hospital stay was overall 9 days (SD 4.3) in the IG versus 10.7 (SD 11.2) among controls, and for cause-specific admissions 9 (SD 4.5) vs. 11.2 (SD 11.8) days, both without statistical significance (p = 0.891 and 0.927, respectively). Four patients need to be telemonitored for a year to prevent one admission (NNT). There were more telephone contacts in the IG than in the CG (22.6 -SD 16.1- vs. 8.6 -SD 7.2-, p = 0.001), but fewer home nursing visits (15.3 -SD 11.6- vs. 25.4 -SD 26.3-, respectively), though the difference was not statistically significant (p = 0.3603).
  
  
  CONCLUSIONS
  This study shows that telemonitoring of in-home patients with HF and/or CLD notably increases the percentage of patients with no hospital admissions and indicates a trend to reduce total and cause-specific hospitalisations and hospital stay. Home telemonitoring can constitute a beneficial alternative mode of healthcare provision for medically unstable elderly patients.
  
  
  BACKGROUND
  Current Controlled Trials ISRCTN89041993.
authors.affiliation: Bilbao Primary Care Health Region, Osakidetza - Basque Health Service, Bizkaia, Spain. INAKI.MARTINLESENDE@osakidetza.net
authors.forename: Iñaki
authors.initials: I
authors.lastname: Martín-Lesende
authors.forename: Estibalitz
authors.initials: E
authors.lastname: Orruño
authors.forename: Amaia
authors.initials: A
authors.lastname: Bilbao
authors.forename: Itziar
authors.initials: I
authors.lastname: Vergara
authors.forename: M Carmen
authors.initials: MC
authors.lastname: Cairo
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Bayón
authors.forename: Eva
authors.initials: E
authors.lastname: Reviriego
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Romo
authors.forename: Jesús
authors.initials: J
authors.lastname: Larrañaga
authors.forename: José
authors.initials: J
authors.lastname: Asua
authors.forename: Roberto
authors.initials: R
authors.lastname: Abad
authors.forename: Elizabete
authors.initials: E
authors.lastname: Recalde
mesh_terms: D018450:Disease Progression; D006333:Heart Failure / Q000628:therapy*; D006699:Home Care Services; D006801:Humans; D008297:Male; D011320:Primary Health Care; D029424:Pulmonary Disease, Chronic Obstructive / Q000628:therapy*; D013686:Telemetry; D017211:Treatment Failure
references.citation: IEEE Trans Inf Technol Biomed. 2006 Jul;10(3):567-73
references.pmid: 16871726
references.citation: Telemed J E Health. 2011 May;17(4):254-61
references.pmid: 21476945
references.citation: N Engl J Med. 2010 Dec 9;363(24):2301-9
references.pmid: 21080835
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: BMC Health Serv Res. 2011 Mar 08;11:56
references.pmid: 21385401
references.citation: J Telemed Telecare. 2010;16(2):68-76
references.pmid: 20008054
references.citation: Cochrane Database Syst Rev. 2010 Aug 04;(8):CD007228
references.pmid: 20687083
references.citation: Int J Cardiol. 2009 Jan 9;131(2):192-9
references.pmid: 18222552
references.citation: BMC Med Inform Decis Mak. 2012 Nov 30;12:139
references.pmid: 23194420
references.citation: J Am Coll Cardiol. 2005 May 17;45(10):1654-64
references.pmid: 15893183
references.citation: Cochrane Database Syst Rev. 2000;(2):CD002098
references.pmid: 10796678
references.citation: J Telemed Telecare. 2010;16(3):120-7
references.pmid: 20197355
references.citation: Arch Intern Med. 2003 Mar 10;163(5):585-91
references.pmid: 12622605
references.citation: BMC Health Serv Res. 2011 Aug 05;11:184
references.pmid: 21819569
references.citation: BMJ. 2007 May 5;334(7600):942
references.pmid: 17426062
references.citation: J Am Coll Cardiol. 2009 Oct 27;54(18):1683-94
references.pmid: 19850208
references.citation: Arch Intern Med. 2012 May 28;172(10):773-9
references.pmid: 22507696
references.citation: Prog Cardiovasc Nurs. 2008 Winter;23(1):18-26
references.pmid: 18326990
references.citation: Stat Med. 2001 Dec 30;20(24):3947-62
references.pmid: 11782045
references.citation: BMC Health Serv Res. 2012 Apr 16;12:95
references.pmid: 22507694
references.citation: BMJ. 2012 Jun 21;344:e3874
references.pmid: 22723612
references.citation: Med Care. 1986 Jan;24(1):67-74
references.pmid: 3945130